T. Yamagata

发表

Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug-Drug Interaction Risk Assessment Decision Criteria

M. Jamei, X. Chu, K. Hillgren, 2013, Drug Metabolism and Disposition.

Drug delivery system based on transport characteristics of biological membranes Oral drug delivery system based on controlling intestinal transporter function

M. Morishita, T. Yamagata, 2006 .

Characterization of the inhibition of breast cancer resistance protein-mediated efflux of mitoxantrone by pharmaceutical excipients.

Yuichi Sugiyama, Tetsuo Yamagata, Kozo Takayama, 2009, International journal of pharmaceutics.

Comparison of methods for the prediction of human clearance from hepatocyte intrinsic clearance for a set of reference compounds and an external evaluation set

T. Yamagata, U. Zanelli, H. Dolgos, 2017, Xenobiotica; the fate of foreign compounds in biological systems.

Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption.

Nicholas A Peppas, Marc C Torjman, Tetsuo Yamagata, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Effect of excipients on breast cancer resistance protein substrate uptake activity.

Yuichi Sugiyama, Tetsuo Yamagata, Kozo Takayama, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Application of Receiver Operating Characteristic Analysis to Refine the Prediction of Potential Digoxin Drug Interactions

Sophie P. Chung, Shibing Deng, M. Jamei, 2013, Drug Metabolism and Disposition.

DMD050542 1367..1374

Sophie P. Chung, Shibing Deng, M. Jamei, 2013 .

In vitro and in vivo drug disposition of cilengitide in animals and human

T. Yamagata, H. Scheible, H. Dolgos, 2016, Pharmacology research & perspectives.

Key functions in polymer carriers for intestinal absorption of insulin.

N. Kamei, A. Lowman, M. Morishita, 2008, International journal of pharmaceutics.

Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids.

N. Peppas, M. Morishita, K. Takayama, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Improvement of the Oral Drug Absorption of Topotecan through the Inhibition of Intestinal Xenobiotic Efflux Transporter, Breast Cancer Resistance Protein, by Excipients

Yuichi Sugiyama, Tetsuo Yamagata, Kozo Takayama, 2007, Drug Metabolism and Disposition.

Comparison of methods for the prediction of human clearance from hepatocyte intrinsic clearance for a set of reference compounds and an external evaluation set

T. Yamagata, U. Zanelli, H. Dolgos, 2017, Xenobiotica; the fate of foreign compounds in biological systems.